Ontology highlight
ABSTRACT: Background
Insomnia is common in breast cancer survivors (BCS), affecting an estimated 30-50% of the 3.8 million BCS in the US. Insomnia is associated with health consequences for cardiometabolic and immune systems, neurobehavioral function, depression, fatigue, and quality of life and may put BCS at particular risk. While pharmacotherapy for insomnia may address symptoms in the short-term, cognitive behavioral therapy for insomnia (CBT-I) is considered the gold standard insomnia treatment. We describe our protocol to determine the efficacy of voice-activated delivery of CBT-I components on insomnia symptoms compared to a sleep education control among BCS.Methods
We will conduct a 6-week, randomized controlled trial with two arms. Intervention arm participants will receive
SUBMITTER: Starling CM
PROVIDER: S-EPMC9210637 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature